For the Inventor, By the Inventor

Enter inventor name

Essex, United Kingdom

Graham Peter Jones

USPTO Granted Patents = 25 (Patent Applications = 5)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 171(Granted Patents)

Location History:

Sawston, GB (1991 - 1993)
Cambridge, GB (1992 - 1999)
Saffron Walden, GB (2012 - 2014)
Essex, GB (2016 - 2024)

Company Filing History:

15 out of 1,500

Schering Agrochemicals Limited

Institute for Oneworld Health

Agrevo UK Limited

Path Drug Solutions

7. 1 out of 1,384

Schering Aktiengesellschaft

Years Active: 1991-2024

Loading Chart...

Loading Chart...

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12054465 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2024-08-06),

2. 11814359 - Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-11-14),

3. 11773069 - Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-10-03),

4. 11680049 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-20),

5. 11673872 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-13),

6. 11673871 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-13),

7. 11667615 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-06),

8. 11655224 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

9. 11655223 - Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

10. 11655222 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

11. 11655221 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

12. 11117874 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2021-09-14),

13. 10669245 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors (2020-06-02),

14. 10287258 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2019-05-14),

15. 9522894 - [object Object] (2016-12-20),

Title: The Innovative Journey of Graham P Jones

Introduction:

Graham P Jones, a talented inventor based in Cambridge, GB, has made significant contributions to the field of herbicidal sulfonamides. With a total of 7 patents to his name, Jones is known for his groundbreaking work in developing effective sulfonamide herbicides.

Latest Patents:

One of Jones's latest patents includes the creation of herbicidal sulfonamides that feature a unique chemical formula. These sulfonamides are designed to target specific types of weeds, providing an innovative solution for agricultural purposes.

Career Highlights:

Throughout his career, Graham P Jones has worked with prominent companies such as Schering Agrochemicals Limited and Agrevo UK Limited. His experience in these organizations has helped shape his expertise in developing cutting-edge herbicidal products.

Collaborations:

Jones has collaborated with skilled professionals in the field, including Peter S Gates and David Edward Saunders. Together, they have worked on various projects aimed at improving the efficiency and efficacy of herbicidal sulfonamides.

Conclusion:

In conclusion, Graham P Jones's dedication to innovation and his remarkable contributions to the development of herbicidal sulfonamides have solidified his reputation as a respected inventor in the industry. His continued pursuit of excellence serves as an inspiration to aspiring inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…